PL3880217T3 - Sposoby otrzymywania materiału uwalnianego z płytek krwi - Google Patents

Sposoby otrzymywania materiału uwalnianego z płytek krwi

Info

Publication number
PL3880217T3
PL3880217T3 PL19800906.0T PL19800906T PL3880217T3 PL 3880217 T3 PL3880217 T3 PL 3880217T3 PL 19800906 T PL19800906 T PL 19800906T PL 3880217 T3 PL3880217 T3 PL 3880217T3
Authority
PL
Poland
Prior art keywords
methods
platelet releasate
preparing platelet
preparing
releasate
Prior art date
Application number
PL19800906.0T
Other languages
English (en)
Inventor
Hendrik B FEYS
Philippe VANDEKERCKHOVE
Veerle Compernolle
Original Assignee
Onderzoeks en Ontwikkelingsfonds Rode Kruis-Vlaanderen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Onderzoeks en Ontwikkelingsfonds Rode Kruis-Vlaanderen filed Critical Onderzoeks en Ontwikkelingsfonds Rode Kruis-Vlaanderen
Publication of PL3880217T3 publication Critical patent/PL3880217T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/983—Blood, e.g. plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Lubricants (AREA)
PL19800906.0T 2018-11-14 2019-11-14 Sposoby otrzymywania materiału uwalnianego z płytek krwi PL3880217T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18206107 2018-11-14
PCT/EP2019/081257 WO2020099530A1 (en) 2018-11-14 2019-11-14 Methods for preparing platelet releasate

Publications (1)

Publication Number Publication Date
PL3880217T3 true PL3880217T3 (pl) 2024-05-20

Family

ID=64316317

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19800906.0T PL3880217T3 (pl) 2018-11-14 2019-11-14 Sposoby otrzymywania materiału uwalnianego z płytek krwi

Country Status (11)

Country Link
US (2) US12310989B2 (pl)
EP (1) EP3880217B1 (pl)
JP (1) JP7416786B2 (pl)
KR (1) KR20210091760A (pl)
CN (1) CN113164522B (pl)
AU (1) AU2019380640B2 (pl)
CA (1) CA3113888A1 (pl)
ES (1) ES2970156T3 (pl)
IL (1) IL282359B2 (pl)
PL (1) PL3880217T3 (pl)
WO (1) WO2020099530A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7210465B2 (ja) * 2016-11-18 2023-01-23 パワー オブ プレートレッツ ピーティーイー リミテッド 成長因子含有血小板放出物を調製する方法
ES2934719A1 (es) * 2021-08-24 2023-02-24 Fundacion Para La Investig E Innovacion Biosanitaria Del Principado De Asturias Finba Método para obtener un secretoma derivado de plaquetas y usos del mismo
EP4276173A1 (en) * 2022-05-10 2023-11-15 Stemmatters, Biotecnologia e Medicina Regenerativa, S.A. Stable human platelet lysate composition, methods and uses thereof
CN115125191B (zh) * 2022-08-22 2023-10-13 浙江绿蔻生物技术有限公司 成纤维细胞转化培养基及其应用、成纤维细胞的制备方法
WO2024159177A1 (en) * 2023-01-26 2024-08-02 Regenexx Llc Use of platelet lysate to return macrophage cells to their resting state
WO2025078407A1 (en) 2023-10-09 2025-04-17 Onderzoeks- En Ontwikkelingsfonds Rode Kruis- Vlaanderen Methods for preparing growth factor-rich releasate

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340049A (en) 1979-10-18 1982-07-20 Baxter Travenol Laboratories, Inc. Breakaway valve
JPS6420858A (en) 1987-07-16 1989-01-24 Terumo Corp Tube body equipped with plug body separable by breakage
JP4110285B2 (ja) 2003-03-07 2008-07-02 愛知県 血清の製造方法
US8796017B2 (en) 2003-05-21 2014-08-05 Jms Co., Ltd. Container for preparing serum and regenerative medical process using the same
US7678780B2 (en) * 2003-12-29 2010-03-16 Allan Mishra Method of treating cancer using platelet releasate
US7694828B2 (en) * 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
GB201004072D0 (en) 2010-03-11 2010-04-28 Turzi Antoine Process, tube and device for the preparation of wound healant composition
US20120230967A1 (en) * 2011-03-08 2012-09-13 Howmedica Osteonics Corp. Device and method to activate platelets
US9011846B2 (en) 2011-05-02 2015-04-21 Biomet Biologics, Llc Thrombin isolated from blood and blood fractions
CN108671224B (zh) * 2011-06-27 2022-12-13 爱默蕾大学 血小板裂解物的组合物、用途和制备
ES2675693T3 (es) * 2011-07-06 2018-07-11 Cell Therapy Limited Células progenitoras de linaje mesodérmico
JP6452271B2 (ja) 2012-12-13 2019-01-16 株式会社ジェイ・エム・エス 血清の調製方法
US20160002598A1 (en) * 2013-01-28 2016-01-07 Regenerative Science, LLC Device and methods for platelet lysis or activation
GB201411913D0 (en) 2014-07-03 2014-08-20 Lb46 Ltd Cosmetic methods and products

Also Published As

Publication number Publication date
CA3113888A1 (en) 2020-05-22
EP3880217B1 (en) 2024-01-03
EP3880217A1 (en) 2021-09-22
IL282359A (en) 2021-05-31
US20220008475A1 (en) 2022-01-13
ES2970156T3 (es) 2024-05-27
IL282359B1 (en) 2023-10-01
AU2019380640B2 (en) 2024-11-28
WO2020099530A1 (en) 2020-05-22
AU2019380640A1 (en) 2021-04-22
CN113164522A (zh) 2021-07-23
EP3880217C0 (en) 2024-01-03
US20250276019A1 (en) 2025-09-04
JP2022509053A (ja) 2022-01-20
JP7416786B2 (ja) 2024-01-17
US12310989B2 (en) 2025-05-27
IL282359B2 (en) 2024-02-01
KR20210091760A (ko) 2021-07-22
CN113164522B (zh) 2024-08-27

Similar Documents

Publication Publication Date Title
IL275657A (en) C-KIT antibodies
ZA201903946B (en) A method for preparing a growth factors containing platelet releasate
IL282359A (en) Methods for the preparation of lysate from fermentations
ZA201606844B (en) Method for preparing amg 416
EP3558312A4 (en) VASCULAR DENSITY IMPROVEMENT PROCESSES
GB201714269D0 (en) Methods for preparing supported zeolite films
ZA201806249B (en) Antibodies for il-17c
IL283331A (en) Method for the preparation of n-phenylpyrazole-1-carboxamides
GB201905146D0 (en) Method for preparing aronatic hydrocarbons
IL259557A (en) Methods for the preparation of modified 6,5-dihydro-6-phenyl-benzo[f]isoquinoline-2-amine
IL271233A (en) Quinolinicyclohexylpropanamide-modified compounds and improved methods for their preparation
ZA201903463B (en) Method for preparing hexadecahydropyrene
IL260070B (en) A method for the preparation of converted 2-aryl-ethanols
LT3390358T (lt) Kristalinis eravaciklino bis-hidrochloridas
GB201820754D0 (en) Methods for preparing compounds
IL281635A (en) A synthetic method for the preparation of Alkoxymethylene-Benzoyllactonitrile
GB201820749D0 (en) Methods for preparing compounds
GB201815695D0 (en) Synthetic method
GB201815696D0 (en) Synthetic method
PT3416983T (pt) Anticorpos para il-17c
GB201712304D0 (en) Synthetic methods
GB201709297D0 (en) Method for preparing methylprrolidones
AU2016905310A0 (en) Methods for enhancing vascular density